- Report
- April 2020
- 65 Pages
Global
- Report
- April 2022
- 250 Pages
Asia Pacific
From €2266EUR$2,490USD£1,943GBP
- Report
- November 2022
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- July 2022
- 44 Pages
Kuwait
From €4414EUR$4,850USD£3,784GBP
- Report
- July 2022
- 42 Pages
Libya
From €4414EUR$4,850USD£3,784GBP
- Report
- May 2022
- 120 Pages
India
From €4414EUR$4,850USD£3,784GBP
- Report
- January 2024
- 437 Pages
Global
From €3185EUR$3,500USD£2,731GBP
€4551EUR$5,000USD£3,901GBP
- Report
- January 2024
- 262 Pages
Global
From €3185EUR$3,500USD£2,731GBP
€4551EUR$5,000USD£3,901GBP
- Report
- July 2022
- 302 Pages
Global
From €3185EUR$3,500USD£2,731GBP
€4551EUR$5,000USD£3,901GBP
- Report
- December 2020
Global
From €3822EUR$4,200USD£3,277GBP
€5461EUR$6,000USD£4,681GBP
- Report
- September 2022
- 175 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Report
- October 2021
- 152 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- April 2023
- 90 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 100 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 100 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 188 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
From €3185EUR$3,500USD£2,731GBP
- Report
- November 2023
- 90 Pages
Germany
From €3185EUR$3,500USD£2,731GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more